It Starts With People and Grows With Capital
Arkin Capital is a leading multi-asset manager with over $2 billion under management across VC, PE, and Hedge Funds
Where We Excel: Strategic Areas of Expertise
Arkin leverages four main Investment arms to drive growth and deliver impactful investments through Arkin Health, Arkin Equity, Arkin Tech, and Arkin Real Estate.
A leader in health technologies, this arm invests in early to late-stage biotech, digital health startups, and public pharmaceutical companies, accelerating life-changing therapies and driving the future of healthcare.
A multi-asset manager led by experienced Investment experts, focused on private equity and Israeli public markets. This arm manages multiple capital pools, providing the flexibility to seize opportunities.
Investing primarily in early-stage companies with a focus on strong founders and diversified technologies, this arm has made over 30 notable investments, including Digital Ocean, Lendbuzz, Via, and HoneyBook.
A leading investor in global real estate opportunities, this arm is active across North America and Europe via various vehicles and investment strategies in the residential, commercial, and industrial markets.
Portfolio Highlights
Discover our portfolio companies across different investment activities.
Explore All CompaniesKeros Therapeutics
Keros is a clinical-stage company developing innovative therapies targeting disorders linked to the TGF-ß protein family.
Arkin Entry Stage
Late
Status
IPO
Location
Boston, MA
Funded by
Arkin Bio
HI-Bio
HI-Bio is a biotechnological company that develops specific antibodies to treat autoimmune and inflammatory diseases.
Arkin Entry Stage
Clinical
Status
M&A
Location
San Francisco, CA
Funded by
Arkin Bio
Eleos
Ambient VoiceAI workflow solutions to drive operational efficiency for behavioral health providers.
Arkin Entry Stage
Seed
Status
Active
Location
Boston & TLV
Funded by
Arkin Digital Health
Laguna
Empowering care management with conversational AI.
Arkin Entry Stage
Seed
Status
Active
Location
NYC & TLV
Funded by
Arkin Digital Health
Cellebrite
Cellebrite provides advanced digital intelligence solutions in forensics, data extraction, and analytics for law enforcement and enterprises.
Status
IPO
Location
Israel
Industry
Cybersecurity
Funded by
Arkin Private Equity
TopGum Industries
TopGum Industries specializes in gummy supplements featuring its patented sugar-free Gummiceuticals™.
Status
IPO
Location
Israel
Industry
FoodTech
Funded by
Arkin Private Equity
Reches Real Estate
Reches Real Estate focuses on high-yield industrial and logistics properties in Israel, covering 270,000 sq. meters.
Status
Active
Location
Israel
Industry
Real Estate
Funded by
Arkin Foundry
Fu-Gen
Fu-Gen Develops and manages renewable energy projects in the Nordics, with 215 MW operational and 9 GW in development.
Status
Active
Location
Sweden
Industry
Sustainable Energy
Funded by
Arkin Foundry
DigitalOcean
DigitalOcean delivers affordable cloud solutions for developers and SMBs, including virtual private servers, managed databases, and containers.
Arkin Entry Stage
Series B
Status
IPO
Location
NYC
Funded by
Arkin Tech
Lendbuzz
Lendbuzz uses AI to provide auto loans to individuals with limited or no credit history, and partnering with car dealerships to boost sales.
Arkin Entry Stage
Seed
Status
Active
Location
Boston, MA
Funded by
Arkin Tech
The Legacy at Baton Rouge
Status
Realized
Location
Baton Rouge, LA
Property Type
Student Housing
Investment Structure
Co-GP Equity
Sponsor
Landmark Properties
Funded by
Arkin Real Estate
Argo Properties NV
Status
Active
Location
Germany
Property Type
Multi-Family
Investment Structure
Corporate Seed Investment
Funded by
Arkin Real Estate
The Minds Behind The Capital
Success is a team effort. Meet the passionate top-tier experts behind it.
























Let’s Get in Touch!
Opens a contact form in a modal dialogContact Form
Fill out this form to get in touch with us
Reach out, We’re Here
*Required fields are marked with an asterisk.
Success
Thank you for reaching out! We’ll come back to you shortly
Error!
Please try again
Stay Ahead with Arkin
Dive into our latest articles, news, and events to gain valuable information